Copyright
©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.112835
Table 1 Quantitative reverse transcription polymerase chain reaction primer sequences
| Target gene | Primer | Sequence (5’-3’) |
| NLRP3 | Forward primer | 5’-GCTTGCCGACGATGCCTTCC-3’ |
| Reverse primer | 5’-GCTGTCATTGTCCTGGTGTCTTCC-3’ | |
| ACTA2 | Forward primer | 5’-TCGTGCTGGACTCTGGAGATGG-3’ |
| Reverse primer | 5’-CCACGCTCAGTCAGGATCTTCATG-3’ | |
| NOX4 | Forward primer | 5’-TCACAGCCTCTACATATGCAAT-3’ |
| Reverse primer | 5’-CAGCAGCATGTAGAAGACAAAG-3’ | |
| CASP1 | Forward primer | 5’-GAAGAAACACTCTGAGCAAGTC-3’ |
| Reverse primer | 5’-GATGATGATCACCTTCGGTTTG-3’ | |
| IL-1β | Forward primer | 5’-GCCAGTGAAATGATGGCTTATT-3’ |
| Reverse primer | 5’-AGGAGCACTTCATCTGTTTAGG-3’ | |
| GAPDH | Forward primer | 5’-GAAGGTGAAGGTCGGAGTC-3’ |
| Reverse primer | 5’-GAAGATGGTGATGGGATTTC-3’ |
- Citation: Zeng FL, Shi MJ, Mo YS, Xiao HM, Xie YB, Chi XL. He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro. World J Hepatol 2025; 17(12): 112835
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/112835.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.112835
